Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Cardiac Failure

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cardfail.2011.03.004PMID 21703533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium.

  2008cited by this paper
• MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium.

  2008cited by this paper
• Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2008cited by this paper
• Science to Practice : Can MR Imaging Be Used to Determine the Efficacy of Gene Therapy in the Heart ?

  2008cited by this paper
• Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model.

  2008cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.

  2007cited by this paper
• A randomized, double‐blind, placebo‐controlled, multicenter, pilot study of the safety and feasibility of catheter‐based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease

  2006cited by this paper
• Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure

  2005cited by this paper
• Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.

  2005cited by this paper
• Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

  2005cited by this paper
• Hepatocyte growth factor as potential cardiovascular therapy

  2005cited by this paper
• Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies

  2004cited by this paper
• Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease

  2004cited by this paper
• Gene Transfer of Hepatocyte Growth Factor Attenuates Postinfarction Heart Failure

  2003cited by this paper
• Vascular growth factors and angiogenesis in cardiac surgery.

  2003cited by this paper
• Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps.

  2003cited by this paper
• Sample handling and stability of hepatocyte growth factor in blood samples.

  2002cited by this paper
• Left ventricular electromechanical mapping: preliminary evidence of electromechanical changes after successful coronary intervention.

  2002cited by this paper
• Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease.

  2002cited by this paper
• Keita Angiogenesis Induced by Human Hepatocyte Growth Factor Gene Impairment of Collateral Formation in Lipoprotein ( a ) Transgenic Mice : Therapeutic

  2002cited by this paper
• Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium.

  2002cited by this paper
• Evaluation of inotropic changes in ventricular function by NOGA mapping: comparison with echocardiography.

  2002cited by this paper
• Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery Disease: Validation by Delayed-Enhancement Magnetic Resonance Imaging

  2002cited by this paper
• Three-dimensional endocardial impedance mapping: a new approach for myocardial infarction assessment.

  2001cited by this paper
• Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris.

  2001cited by this paper
• Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model: Molecular Mechanisms of Delayed Angiogenesis in Diabetes

  2001cited by this paper
• Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction.

  2001cited by this paper
• Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?

  2001cited by this paper
• Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases.

  2000cited by this paper
• Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium.

  1999cited by this paper
• Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.

  1998cited by this paper
• Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability.

  1998cited by this paper
• A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results.

  1997cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

  1994cited by this paper
• Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice.

  1994cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium.

  1987cited by this paper

• The myocardial ischemic cascade network and multi-target synergistic interventions: From molecular mechanisms to therapeutic innovations.

  2026cites this paper
• Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study

  2024cites this paper
• Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction

  2023cites this paper
• Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

  2021cites this paper
• Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model

  2018cites this paper
• Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Angiogenic growth factors in myocardial infarction: a critical appraisal

  2017cites this paper
• Pressing diseases that represent promising targets for gene therapy.

  2017cites this paper
• Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases

  2016cites this paper
• Method for sectioning and sampling hearts for histologic evaluation after delivery of biological agents by transendocardial injection.

  2015cites this paper
• Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

  2013cites this paper
• Surgical Treatment for Diffuse Coronary Artery Diseases

  2013cites this paper
• Nucleic acid delivery: roles in biogerontological interventions.

  2013cites this paper
• Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study

  2012cites this paper